ARCHIVES

In Brief: Outstanding Investigator Awards Draw 150 Letters Of Intent; Applications Due July 15

This article is from The Cancer Letter archive.

Vol. 10 No. 24 | June 15, 1984

Download PDF Visit The Full Archive

Related Articles

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

October 3, 2014

NCI Resources, Services Available For Cancer Research

June 7, 1996

Aspirin Use Associated With Lower Cancer Indicence, Death

April 27, 2007

Patients urge Medicare to allow an open formulary for cancer treatment.

October 15, 2004

NCI Raises New Questions About Duke Genomics Research, Cuts Assay From Trial

May 14, 2010

Avastin Loses Indication for Breast Cancer

November 18, 2011